Foxi, I can't argue with your post. I do believe that Charles wants a clean slate from the past dealings so that he can deal with strength in all negotiations. The audit, new contracts/license agreement PR's will be on hold until Savov matter is done. Patients will be needed by those who are holding and opportunity for new shares continues. When all matters are settled I do believe we will move up significantly as we are very undervalued. The move up will be swift and substantial in my opinion.
Yep, agreed they need to cast off all that's Bulgarian, and have been expressing as much. What people either don't recognize or acknowledge is that those who are allegedly funding the trials in Bulgaria (some partners in IMPL) have too been involved in seediness. I fear that we'll see further skeletons emerging - that the problems affecting the company's image will prove not be confined to Savov.
News 
Market Data 
Discover 
AI
